2009-01-27 - Athera Biotechnologies ABRichter-Helm and Athera have signed an agreement for the development and manufacturing of Athera’s novel product for prevention of plaque rupture and athero-thrombosis through binding of the protein, Annexin A5, to endothelium. The recombinant protein Ann...